Thus, these transferred allogeneic CD8 + CD56+ NKT cells can effectively prime alloimmune T cells of patients to activate cells and reverse tumour microenvironment-induced immune suppression without inducing GVHD. This evidence concerns the gene CD8A and neoplasm.